BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 92.10
+4.79 (5.49%)
At close: Jul 22, 2025, 2:57 PM CST
SHA:688166 Revenue
BrightGene Bio-Medical Technology had revenue of 248.96M CNY in the quarter ending March 31, 2025, a decrease of -26.81%. This brings the company's revenue in the last twelve months to 1.19B, down -1.92% year-over-year. In the year 2024, BrightGene Bio-Medical Technology had annual revenue of 1.28B with 8.74% growth.
Revenue (ttm)
1.19B
Revenue Growth
-1.92%
P/S Ratio
33.59
Revenue / Employee
1.04M
Employees
1,151
Market Cap
40.02B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |